Document is current

Any future updates will be listed below

Rationale and design of the Helping Ease Renal failure with Bupi Yishen compared with the Angiotensin II Antagonist Losartan (HERBAAL) trial: a randomized controlled trial in non-diabetes stage 4 chronic kidney disease

Crossref DOI link: https://doi.org/10.1186/s12906-015-0830-1

Published Online: 2015-09-08

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark